SrProductTherapeutic UseRegulatory Status (USDMF)
1DeferasiroxIron Chelating AgentQ IV 2017
2Dimethyl FumarateRelapsing forms of Multiple SclerosisQ IV 2017
3Eslicarbazepine AcetateAnti-ConvulsantQ III 2017
5Nintedanib EsylateIdiopathic pulmonary fibrosisQ IV 2017
6PirfenidoneFibrosisQ III 2017
7Rolapitant HCLAntiemeticQ IV 2017
9Solifenacin SuccinateOveractive BladderQ I 2017

Note : All Transactions are carried out in conformity with the patent laws applicable in the user country. Responsibility with respect to third party’s patent rights in a specific country lies exclusively with the buyer.

Customized Particle Size Available